dr. ronald petersen on who guidelines for risk reduction of cognitive decline and dementia
Published 5 years ago • 1.9K plays • Length 1:32Download video MP4
Download video MP3
Similar videos
-
2:45
dr. ronald petersen discusses alzheimer's research
-
1:11
mayo clinic minute: reducing risk of alzheimer's disease in families
-
4:24
mild cognitive impairment study -- mayo clinic
-
17:58
alzheimer's disease: mayo clinic radio
-
16:03
brain health strategies -- why and how we can prevent cognitive decline | roger anunsen | tedxsalem
-
1:15:29
the aging but resilient brain: keeping neurons happy
-
13:57
what you can do to prevent alzheimer's | lisa genova | ted
-
18:43
mayo clinic q&a podcast: mayo clinic experts discuss new alzheimer’s treatment option
-
3:10
mayo clinic's better way to test dementia
-
0:59
mayo clinic minute: exercise might be key to slowing cognitive impairment
-
4:03
mild cognitive impairment is more common in men
-
2:38
interview with ronald c. peterson, director, mayo clinic alzheimer’s disease center - iagg 2017
-
1:00
mayo clinic minute: family risk of alzheimer's disease?
-
0:38
ron petersen, md, on alzheimer's disease funding
-
23:51
ronald peterson
-
2:44
beware of pre-dementia
-
1:02:09
international action on dementia event - ron peterson
-
1:37
mayo clinic expert explains why a change is needed when talking about dementia
-
42:47
ron petersen - dsm-v: renaming dementia
-
1:49
dr. ronald petersen discusses pat summitt and early-onset alzheimer's
-
0:59
dr. ronald petersen - donanemab is a drug that reduces one of the proteins that defines alzheimer's